Girard Partners Ltd. Abbott Laboratories Transaction History

Girard Partners Ltd.

  • $1.06 Billion
  • Q1 2024

A detailed history of Girard Partners Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Girard Partners Ltd. holds 27,255 shares of ABT stock, worth $2.84 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
27,255
Previous 30,091 9.42%
Holding current value
$2.84 Million
Previous $3.31 Million 6.49%
% of portfolio
0.29%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$109.52 - $120.96 $310,598 - $343,042
-2,836 Reduced 9.42%
27,255 $3.1 Million
Q4 2023

Feb 09, 2024
SELL
$90.19 - $110.4 $1.41 Million - $1.73 Million
-15,653 Reduced 34.22%
30,091 $3.31 Million
Q3 2023

Nov 02, 2023
SELL
$95.53 - $114.62 $2.79 Million - $3.34 Million
-29,177 Reduced 38.94%
45,744 $4.43 Million
Q2 2023

Aug 15, 2023
BUY
$100.78 - $112.29 $664,341 - $740,215
6,592 Added 9.65%
74,921 $8.17 Million
Q1 2023

May 12, 2023
BUY
$96.86 - $114.01 $232,754 - $273,966
2,403 Added 3.64%
68,329 $6.92 Million
Q4 2022

Jan 26, 2023
BUY
$95.06 - $111.52 $21,103 - $24,757
222 Added 0.34%
65,926 $0
Q3 2022

Oct 20, 2022
BUY
$96.76 - $112.03 $61,732 - $71,475
638 Added 0.98%
65,704 $6.36 Million
Q2 2022

Jul 26, 2022
SELL
$102.07 - $123.37 $69,713 - $84,261
-683 Reduced 1.04%
65,066 $7.07 Million
Q1 2022

Apr 27, 2022
BUY
$114.02 - $139.04 $788,676 - $961,739
6,917 Added 11.76%
65,749 $7.78 Million
Q4 2021

Feb 02, 2022
SELL
$115.53 - $141.46 $79,715 - $97,607
-690 Reduced 1.16%
58,832 $8.28 Million
Q3 2021

Nov 01, 2021
BUY
$116.66 - $129.06 $6.12 Million - $6.77 Million
52,491 Added 746.57%
59,522 $7.03 Million
Q3 2021

Nov 01, 2021
SELL
$116.66 - $129.06 $6.26 Million - $6.93 Million
-53,684 Reduced 88.42%
7,031 $7.03 Million
Q2 2021

Aug 10, 2021
BUY
$105.79 - $124.53 $3,385 - $3,984
32 Added 0.05%
60,715 $7.04 Million
Q1 2021

May 06, 2021
SELL
$108.84 - $128.23 $70,528 - $83,093
-648 Reduced 1.06%
60,683 $7.27 Million
Q4 2020

Feb 02, 2021
SELL
$105.0 - $114.42 $214,305 - $233,531
-2,041 Reduced 3.22%
61,331 $6.72 Million
Q3 2020

Nov 13, 2020
SELL
$91.64 - $111.29 $367,476 - $446,272
-4,010 Reduced 5.95%
63,372 $6.9 Million
Q2 2020

Aug 10, 2020
SELL
$76.57 - $98.0 $411,870 - $527,142
-5,379 Reduced 7.39%
67,382 $6.16 Million
Q1 2020

May 01, 2020
BUY
$62.82 - $91.86 $223,262 - $326,470
3,554 Added 5.14%
72,761 $5.74 Million
Q4 2019

Feb 03, 2020
SELL
$78.51 - $87.4 $161,259 - $179,519
-2,054 Reduced 2.88%
69,207 $6.01 Million
Q3 2019

Nov 01, 2019
SELL
$81.84 - $88.74 $1.13 Million - $1.23 Million
-13,828 Reduced 16.25%
71,261 $5.96 Million
Q2 2019

Aug 12, 2019
SELL
$72.88 - $85.0 $291,447 - $339,915
-3,999 Reduced 4.49%
85,089 $7.16 Million
Q1 2019

May 08, 2019
SELL
$66.22 - $80.06 $365,137 - $441,450
-5,514 Reduced 5.83%
89,088 $7.12 Million
Q4 2018

Feb 11, 2019
SELL
$65.56 - $74.27 $470,065 - $532,515
-7,170 Reduced 7.05%
94,602 $6.84 Million
Q3 2018

Nov 09, 2018
SELL
$60.81 - $73.36 $178,598 - $215,458
-2,937 Reduced 2.8%
101,772 $7.47 Million
Q2 2018

Aug 07, 2018
BUY
$57.57 - $63.54 $6.03 Million - $6.65 Million
104,709 New
104,709 $6.39 Million
Q1 2018

Apr 18, 2018
SELL
$56.27 - $63.62 $5.99 Million - $6.78 Million
-106,499 Closed
0 $0
Q4 2017

Feb 07, 2018
BUY
$53.68 - $57.47 $50,942 - $54,539
949 Added 0.9%
106,499 $6.08 Million
Q3 2017

Nov 08, 2017
SELL
$48.06 - $53.64 $13,697 - $15,287
-285 Reduced 0.27%
105,550 $5.63 Million
Q2 2017

Aug 08, 2017
BUY
N/A
105,835
105,835 $5.15 Million

Others Institutions Holding ABT

# of Institutions
3,130
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.71M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email